Skip to content

Clinical trials

Phase 2 Renal Insufficiency, Chronic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 2 Country / region: Canada Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20103
20111
20123
20132
20151
20161
20172
20201
20214
20224
20231
20245
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
GlaxoSmithKline5
Boehringer Ingelheim3
Bayer2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
AMAG Pharmaceuticals, Inc.1
AbbVie (prior sponsor, Abbott)1
Alnylam Pharmaceuticals1
Dr. Rachel Holden1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic33
Anemia6
Diabetes Mellitus, Type 26
Diabetic Nephropathies5
Kidney Failure, Chronic5
Renal Insufficiency4
Kidney Diseases3
Hypertension2
Obesity2
Proteinuria2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.